Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Stockholm

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Plos Biology|October 26, 2022
Global genome decompaction leads to stochastic activation of gene expression as a first step toward fate commitment in human hematopoietic cellsRomuald Parmentier, Laëtitia Racine, Alice Moussy, et al.
BMC Genetics|April 1, 2009
Robust physical methods that enrich genomic regions identical by descent for linkage studies: confirmation of a locus for osteogenesis imperfectaPeter Brooks, Charles Marcaillou, Maud Vanpeene, et al.
Annals of Clinical and Translational Neurology|April 16, 2016
Natural history of LGMD2A for delineating outcome measures in clinical trialsIsabelle Richard, Jean-Yves Hogrel, Daniel Stockholm, et al.
Acta Biomaterialia|October 12, 2017
Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particlesLouic S Vermeer, Loic Hamon, Alicia Schirer, et al.
BMC Biology|March 12, 2024
Differentiation is accompanied by a progressive loss in transcriptional memoryCamille Fourneaux, Laëtitia Racine, Catherine Koering, et al.
Blood|October 24, 2002
Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiencyFrank Yates, Michèle Malassis-Séris, Daniel Stockholm, et al.
Plos One|June 6, 2012
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathyWilliam Lostal, Marc Bartoli, Carinne Roudaut, et al.
Blood|September 22, 2005
Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicityChantal Lagresle-Peyrou, Frank Yates, Michèle Malassis-Séris, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cellsFatine Benjelloun, Alexandrine Garrigue, Corinne Demerens-de Chappedelaine, et al.
Science Advances|October 22, 2025
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophyAbbass Jaber, Laura Palmieri, Rania Bakour, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Plos Biology|October 26, 2022
Global genome decompaction leads to stochastic activation of gene expression as a first step toward fate commitment in human hematopoietic cellsRomuald Parmentier, Laëtitia Racine, Alice Moussy, et al.
BMC Genetics|April 1, 2009
Robust physical methods that enrich genomic regions identical by descent for linkage studies: confirmation of a locus for osteogenesis imperfectaPeter Brooks, Charles Marcaillou, Maud Vanpeene, et al.
Annals of Clinical and Translational Neurology|April 16, 2016
Natural history of LGMD2A for delineating outcome measures in clinical trialsIsabelle Richard, Jean-Yves Hogrel, Daniel Stockholm, et al.
Acta Biomaterialia|October 12, 2017
Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particlesLouic S Vermeer, Loic Hamon, Alicia Schirer, et al.
BMC Biology|March 12, 2024
Differentiation is accompanied by a progressive loss in transcriptional memoryCamille Fourneaux, Laëtitia Racine, Catherine Koering, et al.
Blood|October 24, 2002
Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiencyFrank Yates, Michèle Malassis-Séris, Daniel Stockholm, et al.
Plos One|June 6, 2012
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathyWilliam Lostal, Marc Bartoli, Carinne Roudaut, et al.
Blood|September 22, 2005
Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicityChantal Lagresle-Peyrou, Frank Yates, Michèle Malassis-Séris, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cellsFatine Benjelloun, Alexandrine Garrigue, Corinne Demerens-de Chappedelaine, et al.
Science Advances|October 22, 2025
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophyAbbass Jaber, Laura Palmieri, Rania Bakour, et al.
Pageof 5